Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept (Q37479419)

20 August 2017

1 reference

title

Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept (English)

1 reference

20 August 2017

0 references

0 references

0 references

Louis Monnier

1

1 reference

PubMed ID

19437415

20 August 2017

Claude Colette

series ordinal

2

1 reference

PubMed ID

19437415

20 August 2017

David R Owens

series ordinal

3

1 reference

20 August 2017

1 July 2009

1 reference

Diabetes - Metabolism: Research and Reviews

20 August 2017

1 reference

20 August 2017

25

1 reference

20 August 2017

5

1 reference

20 August 2017

393-402

1 reference

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations

20 August 2017

1 reference

Carbohydrate metabolism in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?

21 January 2018

1 reference

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

21 January 2018

1 reference

Loss of early insulin secretion leads to postprandial hyperglycaemia

21 January 2018

1 reference

The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications

21 January 2018

1 reference

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

7 January 2021

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

7 January 2021

Standards of medical care in diabetes--2008.

1 reference

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

7 January 2021

Utility of casual postprandial glucose levels in type 2 diabetes management

1 reference

7 January 2021

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

7 January 2021

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

1 reference

7 January 2021

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

7 January 2021

Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

1 reference

7 January 2021

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

1 reference

7 January 2021

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

7 January 2021

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

1 reference

7 January 2021

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

7 January 2021

Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults

1 reference

7 January 2021

Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study

1 reference

7 January 2021

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

7 January 2021

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

7 January 2021

Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

1 reference

7 January 2021

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

1 reference

7 January 2021

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Measurements of glucose control

1 reference

7 January 2021

Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability

1 reference

7 January 2021

Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes.

1 reference

7 January 2021

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

1 reference

7 January 2021

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.

1 reference

7 January 2021

Role of insulin resistance in the pathogenesis of NIDDM.

1 reference

7 January 2021

Quantitation of basal endogenous glucose production in Type II diabetes: importance of the volume of distribution

1 reference

7 January 2021

Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production

1 reference

7 January 2021

The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes Mellitus

1 reference

7 January 2021

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

7 January 2021

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

1 reference

7 January 2021

Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function

1 reference

7 January 2021

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

1 reference

7 January 2021

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

7 January 2021

Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control

1 reference

7 January 2021

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

1 reference

7 January 2021

Postprandial hyperglycemia and diabetes complications: is it time to treat?

1 reference

7 January 2021

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

1 reference

7 January 2021

Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia.

1 reference

7 January 2021

Lipid peroxidation in diabetes mellitus

1 reference

7 January 2021

Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment

1 reference

7 January 2021

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

1 reference

7 January 2021

Role of hyperglycemia in nitrotyrosine postprandial generation

1 reference

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

7 January 2021

The pathobiology of diabetic complications: a unifying mechanism

1 reference

7 January 2021

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients

1 reference

7 January 2021

The effect of glucose variability on the risk of microvascular complications in type 1 diabetes

1 reference

7 January 2021

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited

1 reference

7 January 2021

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial

1 reference

7 January 2021

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

7 January 2021

Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes

1 reference

7 January 2021

Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes.

1 reference

7 January 2021

Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

1 reference

7 January 2021

Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities

1 reference

7 January 2021

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

7 January 2021

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

7 January 2021

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

7 January 2021

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

7 January 2021

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes: Response to Kilpatrick et al

1 reference

7 January 2021

Can interstitial glucose assessment replace blood glucose measurements?

1 reference

7 January 2021

Continuous glucose monitoring and intensive treatment of type 1 diabetes

1 reference

7 January 2021

Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents

1 reference

7 January 2021

Incretin mimetics and DPP-IV inhibitors: new paradigms for the treatment of type 2 diabetes

1 reference

7 January 2021

Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus

1 reference

7 January 2021

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

7 January 2021

Glycemic variability: should we and can we prevent it?

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.962

1 reference

20 August 2017

1 reference

PubMed ID

19437415